SEQUENTIAL HIGH-DOSE METHOTREXATE AND FLUOROURACIL COMBINED WITH DOXORUBICIN - A STEP AHEAD IN THE TREATMENT OF ADVANCED GASTRIC-CANCER - A TRIAL OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER GASTROINTESTINAL-TRACT COOPERATIVE GROUP

被引：340
|
作者：
WILS, JA
KLEIN, HO
WAGENER, DJT
BLEIBERG, H
REIS, H
KORSTEN, F
CONROY, T
FICKERS, M
LEYVRAZ, S
BUYSE, M
DUEZ, N
机构：
[1] DE WEVER HOSP,HEERLEN,NETHERLANDS
[2] UNIV COLOGNE,MED KLIN,W-5000 COLOGNE 41,GERMANY
[3] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
[4] CTR ALEXIS VAUTRIN,F-54500 VANDOEUVRE NANCY,FRANCE
[5] CHU VAUDOIS,CH-1011 LAUSANNE,SWITZERLAND
[6] RADBOUD HOSP,NIJMEGEN,NETHERLANDS
[7] MARIA HILF KRANKENHAUS,MONCHEN GLADBACH,GERMANY
[8] EUROPEAN ORG RES TREATMENT CANC,CTR DATA,BRUSSELS,BELGIUM
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1991年 / 9卷 / 05期
关键词：
D O I：
10.1200/JCO.1991.9.5.827
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In a prospective phase III multicenter trial, 213 patients with advanced measurable or nonmeasurable gastric cancer were randomized to receive methotrexate (MIX), fluorouracil (5-FU), and Adriamycin (doxorubicin; Farmitalia Carlo Erba, Milan, Italy) (FAMTX) or 5-FU, Adriamycin, and mitomycin (FAM). The results show a significantly superior response rate (41% v 9% [P < .0001]), and survival (median, 42 weeks v 29 weeks [P = .004]) for FAMTX. There was a cumulative thrombocytopenia in FAM and not in FAMTX. The FAMTX protocol should be the reference treatment in future clinical trials that seek to improve the therapeutic outcome in advanced gastric cancer. © 1991 by American Society of Clinical Oncology.
引用
收藏
页码：827 / 831
页数：5
相关论文
共 50 条
  • [1] Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European organization for research and treatment of cancer gastrointestinal tract cancer cooperative group
    Vanhoefer, U
    Rougier, P
    Wilke, H
    Ducreux, MP
    Lacave, AJ
    Van Cutsem, E
    Planker, M
    Dos Santos, JG
    Piedbois, P
    Paillot, B
    Bodenstein, H
    Schmoll, HJ
    Bleiberg, H
    Nordlinger, B
    Couvreur, ML
    Baron, B
    Wils, JA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2648 - 2657
  • [2] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (HIGH-DOSE), AND DOXORUBICIN FOR ADVANCED GASTRIC-CANCER
    MURO, H
    ACUNA, LR
    CASTAGNARI, A
    BLAJMAN, C
    SCHMILOVICH, A
    HIDALGO, A
    FIORI, H
    BADER, M
    MARANTZ, A
    CANCER TREATMENT REPORTS, 1986, 70 (11): : 1333 - 1334
  • [3] SEQUENTIAL HIGH-DOSE METHOTREXATE, 5-FLUOROURACIL, AND DOXORUBICIN FOR TREATMENT OF ADVANCED PANCREATIC-CANCER
    SCHEITHAUER, W
    FUNOVICS, J
    MUELLER, C
    LUDWIG, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (02) : 132 - 133
  • [4] A TRIAL OF HIGH-DOSE 5-FLUOROURACIL WITH RAZOXANE OR ADRIAMYCIN IN THE TREATMENT OF ADVANCED ADENOCARCINOMA OF THE GASTROINTESTINAL-TRACT
    SMITH, BJ
    ASHFORD, RFU
    BAKOWSKI, M
    HELLMAN, K
    NEWTON, K
    PHILLIPS, R
    LAMBERT, J
    JONES, R
    PETERS, N
    EVANS, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 481 - 484
  • [5] Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European organization for research and treatment of cancer, gastrointestinal tract cancer cooperative group)
    Rougier, P
    VanPottelsberghe, C
    Kok, T
    Paillot, B
    Wagener, T
    DeGreve, J
    Fabri, MC
    Gerard, B
    VanGlabbeke, M
    Bleiberg, H
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1432 - 1433
  • [6] SEQUENTIAL HIGH-DOSE METHOTREXATE AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    HEIM, ME
    FLECHTNER, H
    EDLER, L
    QUEISSER, W
    TUMORDIAGNOSTIK & THERAPIE, 1986, 7 (05) : 197 - 200
  • [7] ADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN RESECTABLE GASTRIC-CANCER - A RANDOMIZED TRIAL OF THE GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP OF THE EORTC
    BLEIBERG, H
    GOFFIN, JC
    DALESIO, O
    BUYSE, M
    PECTOR, JC
    GIGNOUX, M
    ROUSSEL, A
    SAMANA, G
    MICHEL, J
    GERARD, A
    DUEZ, N
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1989, 15 (06): : 535 - 543
  • [8] AN EORTC GASTROINTESTINAL GROUP EVALUATION OF THE COMBINATION OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL, COMBINED WITH ADRIAMYCIN IN ADVANCED MEASURABLE GASTRIC-CANCER
    WILS, J
    BLEIBERG, H
    DALESIO, O
    BLIJHAM, G
    MULDER, N
    PLANTING, A
    SPLINTER, T
    DUEZ, N
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) : 1799 - 1803
  • [9] Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer
    Takahashi S.
    Kinoshita T.
    Konishi M.
    Nakagouri T.
    Inoue K.
    Ono M.
    Sugitou M.
    Ohtsu A.
    Boku N.
    Yoshida S.
    Gastric Cancer, 2001, 4 (4) : 192 - 197
  • [10] WEEKLY HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID AS SALVAGE TREATMENT IN ADVANCED GASTRIC-CANCER
    VANHOEFER, U
    WILKE, H
    WEH, HJ
    CLEMENS, M
    HARSTRICK, A
    STAHL, M
    HOSSFELD, DK
    SEEBER, S
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 850 - 851
12345